Clinical Trial Update: ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial update reports completion of results for ARV-471 in combination with everolimus in advanced or metastatic estrogen receptor‑positive, HER2‑negat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• ARV-471
• Everolimus (everolimus)

Snippet

Sponsor: Arvinas Estrogen Receptor, Inc. | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED